PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

NCT05609201 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease

Interventions

DIAGNOSTIC_TEST: HRCT Thorax
DEVICE: Glycocheck Endothelial Glycocalyx Assessment
DIAGNOSTIC_TEST: Blood biomarkers
DIAGNOSTIC_TEST: Peripheral leucocyte telomere length
DIAGNOSTIC_TEST: Pulmonary function testing
DIAGNOSTIC_TEST: Patient reported outcome measures

Sponsor

University of Exeter

Collaborators

[object Object]
[object Object]
[object Object]